Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice

Our data in a murine model of lupus document that endogenous EPO reduces T- and B-cell activation and autoantibody production, supporting the conclusion that EPO physiologically acts as a counterregulatory mechanism to control immune homeostasis.